Riskpilot← Back to searchSign inGet full accessEeva-Medical Oy
OYDissolvedY-tunnus 2513259-5Annankatu 4-A22Medical specialists activities · NACE 8622Est. 20121 employees
Revenue 2025
EUR 193K
-14% vs 2024
EBITDA margin
46.6%
-73% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
EUR 71K
-22% vs 2024
| Revenue | EUR 193K | -14% |
| EBITDA | EUR 90K | -73% |
| Net profit | EUR 71K | -22% |
| Total assets | EUR 709K | +1% |
| Equity | EUR 709K | +2% |
| Employees | 1 | — |
Legal name
Eeva-Medical Oy
Y-tunnus number
2513259-5
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
21. marraskuuta 2012
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen sekä kustannustoimionta. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Annankatu 4-A22
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 223 | 219 | 239 | 225 | 193 |
| Staff expenses | −47 | −50 | −54 | 54 | −52 |
| EBITDA | 113 | 111 | 116 | 335 | 90 |
| Depreciation & amort. | — | — | −0 | — | — |
| EBIT | 113 | 111 | 116 | 114 | 90 |
| Net financials | 15 | −4 | 20 | — | — |
| Profit before tax | 128 | 107 | 137 | 116 | 91 |
| Tax | 26 | 26 | 26 | 25 | −20 |
| Net profit | 102 | 81 | 110 | 91 | 71 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 560 | 599 | 657 | 704 | 709 |
| Equity | 558 | 595 | 657 | 695 | 709 |
| Long-term debt | — | — | 0 | — | — |
| Short-term debt | 2 | 4 | 0 | 9 | 0 |
| Total debt | 2 | 4 | 0 | 9 | 0 |
EBITDA margin
46.6%
This company
15.8%
Market median
+195% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
10.0%
This company
18.4%
Market median
-46% vs market
20212025
Net profit margin
36.6%
This company
8.1%
Market median
+352% vs market
20212025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
EJ Chief Executive Officer | Chief Executive Officer | 2012 |
JA | Audit | 2024 |
JP Deputy Member | Deputy Member | 2012 |
KK Deputy auditor | Deputy auditor | 2024 |
| Former (1) | ||
NP | Audit | 2016 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Eeva-Medical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eeva Johanna Jalanko | Chief Executive Officer | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Joni Pekka Jalanko | Deputy Member | 0 companies |
| Niina Pauliina Lettojärvi | Audit | 0 companies |
| Kiri Kasperi Sopanen | Deputy auditor | 0 companies |